NOVARTIS AG-REG (1NOVN.MI) Fundamental Analysis & Valuation

BIT:1NOVN • CH0012005267

Current stock price

135 EUR
+1 (+0.75%)
Last:

This 1NOVN.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1NOVN.MI Profitability Analysis

1.1 Basic Checks

  • 1NOVN had positive earnings in the past year.
  • In the past year 1NOVN had a positive cash flow from operations.
  • 1NOVN had positive earnings in each of the past 5 years.
  • In the past 5 years 1NOVN always reported a positive cash flow from operatings.
1NOVN.MI Yearly Net Income VS EBIT VS OCF VS FCF1NOVN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • 1NOVN has a Return On Assets of 12.60%. This is in the better half of the industry: 1NOVN outperforms 76.92% of its industry peers.
  • 1NOVN has a better Return On Equity (30.31%) than 75.00% of its industry peers.
  • The Return On Invested Capital of 1NOVN (19.32%) is better than 75.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1NOVN is above the industry average of 14.90%.
  • The last Return On Invested Capital (19.32%) for 1NOVN is above the 3 year average (17.15%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.6%
ROE 30.31%
ROIC 19.32%
ROA(3y)13.05%
ROA(5y)12.66%
ROE(3y)29.75%
ROE(5y)27.29%
ROIC(3y)17.15%
ROIC(5y)14%
1NOVN.MI Yearly ROA, ROE, ROIC1NOVN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 24.83%, 1NOVN belongs to the top of the industry, outperforming 82.69% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1NOVN has grown nicely.
  • 1NOVN has a better Operating Margin (33.18%) than 78.85% of its industry peers.
  • In the last couple of years the Operating Margin of 1NOVN has grown nicely.
  • 1NOVN has a better Gross Margin (75.82%) than 75.00% of its industry peers.
  • 1NOVN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 33.18%
PM (TTM) 24.83%
GM 75.82%
OM growth 3Y12.14%
OM growth 5Y6.09%
PM growth 3Y15.69%
PM growth 5Y8.94%
GM growth 3Y0.74%
GM growth 5Y1.28%
1NOVN.MI Yearly Profit, Operating, Gross Margins1NOVN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. 1NOVN.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1NOVN is creating value.
  • The number of shares outstanding for 1NOVN has been reduced compared to 1 year ago.
  • Compared to 5 years ago, 1NOVN has less shares outstanding
  • The debt/assets ratio for 1NOVN is higher compared to a year ago.
1NOVN.MI Yearly Shares Outstanding1NOVN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
1NOVN.MI Yearly Total Debt VS Total Assets1NOVN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B

2.2 Solvency

  • An Altman-Z score of 4.42 indicates that 1NOVN is not in any danger for bankruptcy at the moment.
  • 1NOVN's Altman-Z score of 4.42 is fine compared to the rest of the industry. 1NOVN outperforms 65.38% of its industry peers.
  • The Debt to FCF ratio of 1NOVN is 2.32, which is a good value as it means it would take 1NOVN, 2.32 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.32, 1NOVN is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
  • 1NOVN has a Debt/Equity ratio of 0.64. This is a neutral value indicating 1NOVN is somewhat dependend on debt financing.
  • 1NOVN has a Debt to Equity ratio of 0.64. This is comparable to the rest of the industry: 1NOVN outperforms 48.08% of its industry peers.
  • Although 1NOVN's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 2.32
Altman-Z 4.42
ROIC/WACC3.64
WACC5.31%
1NOVN.MI Yearly LT Debt VS Equity VS FCF1NOVN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • 1NOVN has a Current Ratio of 1.12. This is a normal value and indicates that 1NOVN is financially healthy and should not expect problems in meeting its short term obligations.
  • 1NOVN has a Current ratio of 1.12. This is in the lower half of the industry: 1NOVN underperforms 67.31% of its industry peers.
  • 1NOVN has a Quick Ratio of 1.12. This is a bad value and indicates that 1NOVN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1NOVN has a Quick ratio of 0.89. This is in the lower half of the industry: 1NOVN underperforms 69.23% of its industry peers.
  • The current and quick ratio evaluation for 1NOVN is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.89
1NOVN.MI Yearly Current Assets VS Current Liabilites1NOVN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1NOVN.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 14.98% over the past year.
  • The Earnings Per Share has been growing by 9.21% on average over the past years. This is quite good.
  • The Revenue has grown by 8.91% in the past year. This is quite good.
  • Measured over the past years, 1NOVN shows a small growth in Revenue. The Revenue has been growing by 2.45% on average per year.
EPS 1Y (TTM)14.98%
EPS 3Y13.63%
EPS 5Y9.21%
EPS Q2Q%2.53%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y9.1%
Revenue growth 5Y2.45%
Sales Q2Q%1.39%

3.2 Future

  • 1NOVN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.48% yearly.
  • Based on estimates for the next years, 1NOVN will show a small growth in Revenue. The Revenue will grow by 4.99% on average per year.
EPS Next Y0.69%
EPS Next 2Y4.79%
EPS Next 3Y5.96%
EPS Next 5Y7.48%
Revenue Next Year2.75%
Revenue Next 2Y3.82%
Revenue Next 3Y4.46%
Revenue Next 5Y4.99%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1NOVN.MI Yearly Revenue VS Estimates1NOVN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
1NOVN.MI Yearly EPS VS Estimates1NOVN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. 1NOVN.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.24, 1NOVN is valued on the expensive side.
  • The rest of the industry has a similar Price/Earnings ratio as 1NOVN.
  • The average S&P500 Price/Earnings ratio is at 25.71. 1NOVN is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 17.13, 1NOVN is valued on the expensive side.
  • 1NOVN's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 23.83. 1NOVN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.24
Fwd PE 17.13
1NOVN.MI Price Earnings VS Forward Price Earnings1NOVN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1NOVN.
  • 1NOVN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1NOVN is cheaper than 63.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.5
EV/EBITDA 13.36
1NOVN.MI Per share data1NOVN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1NOVN does not grow enough to justify the current Price/Earnings ratio.
  • 1NOVN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)24.82
PEG (5Y)1.87
EPS Next 2Y4.79%
EPS Next 3Y5.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. 1NOVN.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.06%, 1NOVN has a reasonable but not impressive dividend return.
  • 1NOVN's Dividend Yield is a higher than the industry average which is at 1.92.
  • Compared to an average S&P500 Dividend Yield of 1.91, 1NOVN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.06%

5.2 History

  • The dividend of 1NOVN has a limited annual growth rate of 5.38%.
Dividend Growth(5Y)5.38%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 55.91% of the earnings are spent on dividend by 1NOVN. This is a bit on the high side, but may be sustainable.
  • The dividend of 1NOVN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP55.91%
EPS Next 2Y4.79%
EPS Next 3Y5.96%
1NOVN.MI Yearly Income VS Free CF VS Dividend1NOVN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
1NOVN.MI Dividend Payout.1NOVN.MI Dividend Payout, showing the Payout Ratio.1NOVN.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1NOVN.MI Fundamentals: All Metrics, Ratios and Statistics

NOVARTIS AG-REG

BIT:1NOVN (3/13/2026, 7:00:00 PM)

135

+1 (+0.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners41.7%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap259.04B
Revenue(TTM)56.33B
Net Income(TTM)13.98B
Analysts70.59
Price Target132.6 (-1.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.06%
Yearly Dividend3.5
Dividend Growth(5Y)5.38%
DP55.91%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.14%
Min EPS beat(2)-2.1%
Max EPS beat(2)-0.17%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-2.1%
Max EPS beat(4)6.59%
EPS beat(8)6
Avg EPS beat(8)2.93%
EPS beat(12)9
Avg EPS beat(12)2.91%
EPS beat(16)11
Avg EPS beat(16)2.66%
Revenue beat(2)0
Avg Revenue beat(2)-3.85%
Min Revenue beat(2)-4.89%
Max Revenue beat(2)-2.82%
Revenue beat(4)0
Avg Revenue beat(4)-2.92%
Min Revenue beat(4)-4.89%
Max Revenue beat(4)-1.13%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)5
Avg Revenue beat(12)-2.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.25%
PT rev (3m)13.06%
EPS NQ rev (1m)-1.72%
EPS NQ rev (3m)-7.76%
EPS NY rev (1m)-3.05%
EPS NY rev (3m)-3.46%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-3.1%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 17.24
Fwd PE 17.13
P/S 5.28
P/FCF 19.5
P/OCF 15.53
P/B 6.44
P/tB N/A
EV/EBITDA 13.36
EPS(TTM)7.83
EY5.8%
EPS(NY)7.88
Fwd EY5.84%
FCF(TTM)6.92
FCFY5.13%
OCF(TTM)8.69
OCFY6.44%
SpS25.58
BVpS20.95
TBVpS-4.02
PEG (NY)24.82
PEG (5Y)1.87
Graham Number60.75
Profitability
Industry RankSector Rank
ROA 12.6%
ROE 30.31%
ROCE 22.34%
ROIC 19.32%
ROICexc 22.42%
ROICexgc 94.51%
OM 33.18%
PM (TTM) 24.83%
GM 75.82%
FCFM 27.06%
ROA(3y)13.05%
ROA(5y)12.66%
ROE(3y)29.75%
ROE(5y)27.29%
ROIC(3y)17.15%
ROIC(5y)14%
ROICexc(3y)20.47%
ROICexc(5y)17.14%
ROICexgc(3y)94.66%
ROICexgc(5y)84.88%
ROCE(3y)20.57%
ROCE(5y)16.8%
ROICexgc growth 3Y10.97%
ROICexgc growth 5Y16.26%
ROICexc growth 3Y23.26%
ROICexc growth 5Y13.82%
OM growth 3Y12.14%
OM growth 5Y6.09%
PM growth 3Y15.69%
PM growth 5Y8.94%
GM growth 3Y0.74%
GM growth 5Y1.28%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 2.32
Debt/EBITDA 1.23
Cap/Depr 73.24%
Cap/Sales 6.92%
Interest Coverage 19.05
Cash Conversion 79.71%
Profit Quality 109.01%
Current Ratio 1.12
Quick Ratio 0.89
Altman-Z 4.42
F-Score8
WACC5.31%
ROIC/WACC3.64
Cap/Depr(3y)63.14%
Cap/Depr(5y)55.05%
Cap/Sales(3y)6.73%
Cap/Sales(5y)6.62%
Profit Quality(3y)101.15%
Profit Quality(5y)104.02%
High Growth Momentum
Growth
EPS 1Y (TTM)14.98%
EPS 3Y13.63%
EPS 5Y9.21%
EPS Q2Q%2.53%
EPS Next Y0.69%
EPS Next 2Y4.79%
EPS Next 3Y5.96%
EPS Next 5Y7.48%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y9.1%
Revenue growth 5Y2.45%
Sales Q2Q%1.39%
Revenue Next Year2.75%
Revenue Next 2Y3.82%
Revenue Next 3Y4.46%
Revenue Next 5Y4.99%
EBIT growth 1Y14.46%
EBIT growth 3Y22.35%
EBIT growth 5Y8.7%
EBIT Next Year11.91%
EBIT Next 3Y9.08%
EBIT Next 5Y8.66%
FCF growth 1Y10.42%
FCF growth 3Y9.64%
FCF growth 5Y6.62%
OCF growth 1Y8.66%
OCF growth 3Y10.38%
OCF growth 5Y7%

NOVARTIS AG-REG / 1NOVN.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NOVARTIS AG-REG (1NOVN.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1NOVN.MI.


What is the valuation status for 1NOVN stock?

ChartMill assigns a valuation rating of 4 / 10 to NOVARTIS AG-REG (1NOVN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for NOVARTIS AG-REG?

NOVARTIS AG-REG (1NOVN.MI) has a profitability rating of 8 / 10.


What is the valuation of NOVARTIS AG-REG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NOVARTIS AG-REG (1NOVN.MI) is 17.24 and the Price/Book (PB) ratio is 6.44.


Is the dividend of NOVARTIS AG-REG sustainable?

The dividend rating of NOVARTIS AG-REG (1NOVN.MI) is 6 / 10 and the dividend payout ratio is 55.91%.